Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 24 October 2025

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

Blowout Q3 Results and Rising Orders General Dynamics (NYSE: GD) stunned investors on Oct. 24, 2025, with a blowout third-quarter report. The defense and aerospace giant said Q3 revenue was $12.91 billion – about 10.6% higher than a year ago – beating the ~$12.57 billion analysts expectedbenzinga.com. GAAP earnings per share came in at $3.88, well above the $3.69 consensus estimatebenzinga.combenzinga.com. Operating income was $1.3 billion, and margins expanded by 20 basis points to 10.3%. Management highlighted exceptionally strong demand. “Each of our four segments grew earnings and backlog in the quarter, reflecting solid execution coupled with growing demand,” CEO Phebe Novakovic saidbenzinga.com.
24 October 2025
··
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

Recent FDA Approval and Market Reaction NeurAxis’s Oct. 24, 2025 announcement of FDA 510(k) clearance for its PENFS device immediately grabbed market attention. The clearance authorizes use in adults (8 years and up) for functional abdominal pain associated with FD and nausea, a segment previously lacking any approved device treatmentinvesting.com. Investing.com and other outlets confirm this milestone — noting it’s “the first FDA clearance or approval” for an adult FD treatmentinvesting.com. In pre-market trading on Oct. 24, NRXS shares jumped (around +4% in early quotes) on the news, reflecting relief that FDA evidence support (from pediatric studies) could be extended
24 October 2025
·
Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

The delayed September inflation report – pushed back by the U.S. government shutdown – turned out a bit cooler than expected, reaffirming the narrative that price pressures are easing. The Labor Department said headline CPI rose 0.3% in September (3.0% year-on-year), slightly under the 0.4%/3.1% that economists had forecast reuters.com. Core CPI (excluding food and energy) was up 3.0% YoY (vs 3.1% expected). Wall Street greeted the news calmly, since even at 3% inflation remains above the Fed’s 2% goal. What mattered more was that the softer reading bolsters confidence in near-term rate cuts: U.S. futures now fully price in
24 October 2025
··
Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

Markets Rally as US Inflation Cools Wall Street surged on Oct. 24 after data showed US consumer prices rose less than forecast. The Labor Department’s CPI for September came in at 3.0% year-on-year (3.0% core) vs 3.1% expected xtb.com. That miss drove a rally in stock futures and sent the US dollar slightly lower, while gold and bonds rallied on renewed rate-cut hopes xtb.com reuters.com. As Reuters notes, the dollar index was steady (around 99.06) ahead of the report reuters.com, and traders now fully price a quarter-point Fed cut next week reuters.com reuters.com. “In midday trading, futures on the S&P 500
24 October 2025
··
Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

Market Analysis: Friday’s tame CPI print soothed immediate rate-cut concerns and spurred a relief rally. Futures lifted all sectors, but tech/AI remains a focus. For example, AMD is near $235 after surging ~80% YTD on AI demand ts2.tech, and TSMC hovers near all-time highs (~$294) on chip demand ts2.tech. Mega-cap favorites carry “strong buy” sentiment – Microsoft, Amazon, Walmart and Broadcom top analyst picks ts2.tech. Health and energy also shine: Eli Lilly (~$935) is up on obesity-drug sales (analysts see ~20% more upside) ts2.tech, while refiners benefit from resilient oil prices. Expert Voices: “Valuations continue to be the best argument
24 October 2025
··
Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Stock Slide Hits Ellison’s Fortune Oracle’s spectacular AI-driven rally has turned choppy in recent days. After rocketing to all-time highs in September (briefly valuing Ellison’s stake at ~$393 B) reuters.com, profit-taking set in. The stock plunged about 7% on Oct. 17 (wiping ~$24B off Ellison’s wealth) and sank nearly 5% on Oct. 20 (erasing another ~$14B) financialexpress.com financialexpress.com. The selloff reflects a shift from “euphoria to caution,” as investors booked gains after Oracle’s string of AI contract announcements. By Oct. 23, ORCL closed around $280 ts2.tech – still roughly 70% above its January price, but down from its Sept. peak (~$345). Market watchers describe
24 October 2025
·
P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

Procter & Gamble’s Q1 report beat expectations across the board. Revenue of $22.39 billion (vs. ~$22.17B forecast) and core EPS of $1.99 (vs. $1.90) both topped consensus marketscreener.com. In a statement, P&G credited resilient consumer demand for premium brands. For example, its beauty brands (Pantene, Olay, etc.) delivered roughly 6% organic growth finimize.com – a bright spot after weaker quarters. Grooming and personal care also held up; Bloomberg reports shoppers “brushed off price increases and snapped up the company’s Gillette razors and Secret deodorant,” underpinning the beat bloomberg.com. Overall volumes were flat, but higher pricing and cost savings boosted results.
24 October 2025
·
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Cloud and AI Drive Momentum Microsoft’s Azure cloud has been the standout. In FY2025 Azure revenue surpassed $75B, growing ~34% ts2.tech ts2.tech. Analysts note Azure continues to accelerate: in Q4 it was up ~39%, handily beating AWS and Google Cloud ts2.tech. That dominance is a key reason for the stock’s rally. As TechStock² (TS2.Tech) reports, Wall Street “still sees $600–$650 [over 12 months]” for MSFT ts2.tech. Indeed, banks like UBS and Bank of America recently reiterated Buy ratings and raised targets to ~$650 and $640, respectively insidermonkey.com ts2.tech. UBS “highlighted accelerating Azure growth trends” in its $650 target insidermonkey.com, and
24 October 2025
···
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

As of Oct 24, 2025, RVPH shares trade around $0.57 investing.com, after a volatile October run (ranging roughly $0.26–$0.84). The stock has surged ~28% on Oct 23 (to $0.5675 markets.financialcontent.com) after a prior drop (–23% on Oct 8 benzinga.com). Recent catalysts include completion of a 1-year Phase 3 trial (brilaroxazine OLE) showing robust, sustained efficacy revivapharma.com, and plans for an FDA meeting in Q4 2025 toward a 2026 NDA revivapharma.com. Reviva also raised capital via equity offerings (~$10M in Q2 and ~$9M in Sept revivapharma.com revivapharma.com) to fund its CNS pipeline. Analysts remain extremely bullish – consensus is “Strong Buy”
24 October 2025
···
AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its new AI wins into sustained growth – success could justify prices well above today’s $235, while any misstep might curb the rally. As one analyst quipped, AMD is striving to be the “open, secure, and scalable” AI platform versus Nvidia’s closed box ts2.tech. Whether Wall Street’s bullish forecasts come true will depend on that bet paying off in the years
24 October 2025
··
Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta’s Oct. 24 announcement ignited optimism. According to the official press release, Anemocyte will incorporate Genenta’s clinically validated LVV plasmid DNA platform (originating from Naldini’s research) into its production pipeline investing.com. “By making our clinically validated LVV plasmid DNA technology platform available to Anemocyte and its clients, we are contributing to the reliable and scalable development of advanced therapy programs across the industry,” said CEO Pierluigi Paracchi investing.com. Anemocyte’s CEO Marco Ferrari added that the deal ensures customers have access to “a robust, well-established platform” for cutting-edge cell therapies investing.com. In effect, the partnership helps Genenta and its clients secure
24 October 2025
··
Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Stock Performance and Volatility Plug Power’s share price has been on a roller-coaster. After languishing around $1.50 in late summer 2025, the stock surged to a new 52-week high near $4.58 in early October marketbeat.com ts2.tech. By Oct. 23 it was trading around $2.88 marketbeat.com – still roughly double its summer lows. This sharp rise (≈170% in ~3 months ts2.tech) was driven partly by a classic short squeeze: nearly one-third of Plug’s float was sold short, forcing many bears to cover as positive news hit ts2.tech. Trading volume exploded on rally days (often 2–3× normal levels), reflecting feverish buying. In
24 October 2025
·
Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Market Snapshot: In recent days Ambev stock has been flat-to-up (≈+0.5%). On Oct 24 it traded near $2.20 reuters.com, close to its recent five-week low (~$2.18) and well below its 52-week high ($2.63). Year-to-date returns are modest (roughly +6–8%) reuters.com. Volumes have picked up ahead of Q3 earnings and on broader market swings. The slight uptick Oct 24 followed a series of choppy sessions, suggesting investors are watching for catalysts. Recent Developments: No major company-specific news broke in the past week. The focus is squarely on Ambev’s business trends and upcoming Q3 release (Oct 30). Q2 results (July 31) showed
24 October 2025
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

Stock Performance and Price In late October 2025, IonQ’s share price was around $60 after a tumultuous run. The stock peaked near $82 on Oct. 13 – a 75% year-to-date gain – but then fell back into the $60s ts2.tech ts2.tech. By Oct. 23 (the last full trading day), IonQ closed near $59.4 marketbeat.com. That week, Wednesday’s WSJ news and Thursday’s session saw large intraday swings: the price spiked to about $62.9 mid-day on Oct. 23 before settling around $59–60 marketbeat.com. Trading volume has been very heavy. For example, on Oct. 23 roughly 65 million shares traded hands – nearly triple the typical daily
24 October 2025
·
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

Stock Price and Recent Rally CrowdStrike’s stock has climbed sharply in October. After trading near $484 in mid-October, the share price jumped into the $520s by Oct 23 investing.com. For example, CRWD rose 3.91% on Oct 20 and 4.37% on Oct 23 investing.com, propelled by strong technical momentum and positive headlines. Over the past year the stock is up about 65% ts2.tech, vastly outpacing the S&P 500, as investors bet on its AI-driven growth. Technical indicators have also turned bullish: TipRanks noted on Oct 23 that CRWD’s 20-day exponential moving average (~$490) was well below the then-price (~$504), generating a
24 October 2025
·
Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir and Lumen Forge a New AI Infrastructure Alliance On Oct. 23, Palantir Technologies and Lumen Technologies unveiled a “multi-year, multi-million-dollar” strategic partnership to fuse Palantir’s AI/data platform with Lumen’s high-speed networking. According to the official release, the alliance will help enterprises “deploy AI faster and more securely” by combining Palantir’s Foundry/AIP software with Lumen’s next-generation “Connectivity Fabric” businesswire.com. Bloomberg News had reported Lumen would spend over $200 million on Palantir software aimmediahouse.com reuters.com, making this one of Palantir’s largest commercial deals to date. In a joint Fox Business interview, Palantir CEO Alex Karp stressed the national security stakes: “We’re in
24 October 2025
····
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Stock Price Rallies Amid Mortgage Market Shifts Rocket Companies’ stock has been on a wild ride this year. As of Oct. 24, RKT was trading around $16.94-$17 per sharegoogle.com – roughly flat on the day after some early swings (intraday high ~$17.10, low ~$16.41)google.com. That price is about 70-80% higher than where it started 2025, making Rocket a standout gainer in an otherwise sluggish housing sectoryoutube.com. The stock reached as high as the low-$20s in early October, when excitement over Rocket’s latest acquisition peaked, before cooling off. In fact, RKT shares have climbed about 54% since late March (when its
24 October 2025
·
American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

Financial Results and Upgraded Outlook American Airlines reported mixed but encouraging third-quarter 2025 results, turning in record revenue but a small net loss. Total operating revenue reached $13.69 billion, a quarterly record that was flat versus a year ago but slightly above analyst expectations of ~$13.63 billionstockstory.org. The company posted a net loss of $114 million (roughly -$0.17 per share), which was narrower than feared – analysts had predicted a deeper $0.28 per-share lossstockstory.org. This smaller-than-expected lossreuters.com reflects improved cost management and resilient demand in lucrative segments. In fact, American noted that September turned the corner to positive unit revenue growth, as it
24 October 2025
·
Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Breakthrough Trial Results in Rare Bone Cancer Inhibrx’s lead drug, ozekibart, achieved a landmark win in its ChonDRAgon trial for advanced conventional chondrosarcoma. This rare bone cancer has no approved systemic therapies, so the positive data are significant. According to the company and press accounts, the trial met its primary endpoint with a statistically significant jump in progression-free survival (PFS) biospace.com. Patients on ozekibart lived a median 5.52 months without progression versus 2.66 months on placebo – a 52% reduction in the risk of progression or death biospace.com. All patient subgroups (including those with or without IDH mutations) saw benefit,
24 October 2025
··
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Denison Mines (DNN) Rides Uranium Boom as Wheeler River Advances – What’s Next?

October 24, 2025 – Denison Mines Corp. (NYSE American: DNN) has emerged as one of this year’s hottest mining stocks amid a global uranium frenzy. Below is a summary of key developments and what they mean for the company’s stock and the broader uranium sector: Stock Surge Powered by Nuclear Revival Denison’s stock price has been on a tear this year, reflecting both uranium market tailwinds and the company’s own progress. After languishing near $1 for much of last year, DNN began climbing in mid-2025 alongside uranium’s reboundts2.tech. The rally accelerated this fall: shares hit an intraday 52-week high of
24 October 2025
·
1 … 1,092 1,093 1,094 1,095 1,096 … 1,171

Stock Market Today

Industrial stocks surge, pushing XLI near a 52-week high after Dow cracks 50,000

Industrial stocks surge, pushing XLI near a 52-week high after Dow cracks 50,000

7 February 2026
NEW YORK, February 7, 2026, 13:32 EST — Market closed. U.S. industrial stocks ended the week with a sharp jump, lifting the Industrial Select Sector SPDR Fund (XLI) 2.86% on Friday to $173.18 and leaving it sitting at the top of its 52-week range. (Investing.com) The pop mattered because it came with a rotation away from a narrow tech-led trade and into companies tied more directly to capital spending and the real economy. The Dow Jones Industrial Average closed above 50,000 for the first time, and Caterpillar climbed 7.1% to $726.20; “what’s driven it recently has been the broadening that
Energy stocks set for a geopolitical week after Iran warning and oil rebound

Energy stocks set for a geopolitical week after Iran warning and oil rebound

7 February 2026
U.S. energy stocks rose Friday, with the S&P 500 energy sector up 1.88% and Exxon Mobil gaining 2.03%. Brent crude settled at $68.05 a barrel after Iran threatened U.S. bases if attacked. Saudi Aramco cut March Arab Light crude prices to a five-year low for Asia. Kazakhstan’s CPC Blend exports may drop 35% this month due to Tengiz oilfield disruptions.
Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
Go toTop